Free Trial
NASDAQ:ACT

Enact (ACT) Price, Holdings, & News

$30.69
-0.21 (-0.68%)
(As of 03:21 PM ET)
Today's Range
$30.67
$31.02
50-Day Range
$29.28
$31.74
52-Week Range
$24.26
$31.85
Volume
81,401 shs
Average Volume
265,583 shs
Market Capitalization
$4.83 billion
Assets Under Management
$12.40 million
Dividend Yield
2.83%
Net Expense Ratio
0.75%
ACT stock logo

About Enact (NASDAQ:ACT)

Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. It engages in writing and assuming residential mortgage guaranty insurance. The company also offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; contract underwriting services for mortgage lenders; and mortgage-related reinsurance products. It primarily serves originators of residential mortgage loans. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021. Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. operates as a subsidiary of Genworth Holdings Inc.

ACT Stock Price History

ACT ETF News Headlines

See More Headlines
Receive ACT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enact and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
AdvisorShares
Fund Name
AdvisorShares Vice ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:ACT
Inception Date
12/12/2017
Fund Manager
Dan S. Ahrens, Robert M. Parker

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Developed Markets
Region
North America
Number of Holdings
0

Fund Statistics

Assets Under Management
$12.40 million
Average Daily Volume
$1,652.50
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
AdvisorShares Investments, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
N/A

Miscellaneous

Beta
0.60
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Enact Expenses

TypeACTTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.60%0.57%0.54%0.48%0.51%
Other Expenses0.31%0.72%0.54%0.34%0.58%
Total Expense0.91%0.72%0.70%0.58%0.70%
Fee Waiver-0.16%-0.77%-0.55%-0.22%-0.57%
Net Expense0.75%0.59%0.60%0.54%0.58%

Enact (ACT) Exposure

ACT Sector Exposure

ACT Industry Exposure

Key Executives


ACT ETF - Frequently Asked Questions

Should I buy or sell Enact stock right now?

0 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Enact in the last year. There are currently for the stock. The consensus among Wall Street equities research analysts is that investors should "n/a" ACT shares.
View ACT analyst ratings
or view top-rated stocks.

What is Enact's stock price target for 2024?

0 brokers have issued 12-month target prices for Enact's stock. Their ACT share price targets range from $0.00 to $0.00. On average, they expect the company's share price to reach $0.00 in the next twelve months. This suggests that the stock has a possible downside of 100.0%.
View analysts price targets for ACT
or view top-rated stocks among Wall Street analysts.

How have ACT shares performed in 2024?

Enact's stock was trading at $28.89 at the beginning of the year. Since then, ACT stock has increased by 6.3% and is now trading at $30.72.
View the best growth stocks for 2024 here
.

Are investors shorting Enact?

Enact saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 1,010,000 shares, an increase of 12.8% from the April 30th total of 895,500 shares. Based on an average daily volume of 214,900 shares, the days-to-cover ratio is currently 4.7 days. Currently, 3.3% of the shares of the stock are short sold.
View Enact's Short Interest
.

When is Enact's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 6th 2024.
View our ACT earnings forecast
.

How were Enact's earnings last quarter?

Enact Holdings, Inc. (NASDAQ:ACT) issued its quarterly earnings data on Wednesday, May, 1st. The company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $0.99 by $0.05. The business earned $291.58 million during the quarter, compared to analysts' expectations of $307.29 million. Enact had a trailing twelve-month return on equity of 14.68% and a net margin of 55.87%. During the same quarter in the prior year, the firm earned $1.08 EPS.

How often does Enact pay dividends? What is the dividend yield for Enact?

Enact announced a quarterly dividend on Monday, May 27th. Investors of record on Wednesday, May 29th will be given a dividend of $0.185 per share on Thursday, June 13th. This represents a $0.74 dividend on an annualized basis and a dividend yield of 2.41%. The ex-dividend date is Wednesday, May 29th. This is an increase from the stock's previous quarterly dividend of $0.16.
Read our dividend analysis for ACT
.

What does ACT invest in?

Enact is a equity fund issued by AdvisorShares. ACT focuses on theme investments. The fund's investments total to approximately $12.40 million assets under management.

What is the management fee for Enact?

Enact's management fee is 0.60% and has other expenses of 0.31%. However, ACT has a fee waiver of -0.16% to reimburse the expenses. The net expense ratio for ACT is 0.75%.

What is Dave Page's approval rating as Enact's CEO?

12 employees have rated Enact Chief Executive Officer Dave Page on Glassdoor.com. Dave Page has an approval rating of 100% among the company's employees. This puts Dave Page in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Enact own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Enact investors own include Cara Therapeutics (CARA), Cronos Group (CRON), Innovative Industrial Properties (IIPR), Amplify Alternative Harvest ETF (MJ), Organigram (OGI), Tilray (TLRY), Zynerba Pharmaceuticals (ZYNE) and

When did Enact IPO?

Enact (ACT) raised $253 million in an IPO on Thursday, September 16th 2021. The company issued 13,310,400 shares at a price of $19.00 per share.

Who are Enact's major shareholders?

Enact's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (1.98%), Edgestream Partners L.P. (0.12%), Jacobs Levy Equity Management Inc. (0.12%), Denali Advisors LLC (0.11%), Interval Partners LP (0.09%) and Foundry Partners LLC (0.09%). Insiders that own company stock include Anne G Waleski, Brian Gould, Dominic James Addesso, Genworth Holdings, Inc, Hardin Dean Mitchell and Rohit Gupta.
View institutional ownership trends
.

How do I buy shares of Enact?

Shares of ACT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ACT) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners